Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1976-01-12
1977-08-09
Robinson, Allen J.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
A61K 3114
Patent
active
040411788
ABSTRACT:
Quaternary ammonium compounds such as [2-(4-amino-2,6-dibromophenoxy)ethyl]dimethyl (allyl) ammonium bromide are prepared by the reaction of a tertiary amine such as 3,5-dibromo-.beta.-dimethylamino-p-phenetidine with a substituted organic compound such as allyl bromide. The quaternary ammonium compounds are useful in alleviating or inhibiting cardiac arrhythmias when the quaternary ammonium compounds, or compositions comprising the same are administered to animals.
REFERENCES:
patent: 2895995 (1959-07-01), Willey et al.
patent: 3453313 (1969-07-01), Margot et al.
Huy, Brit. J. Pharmacol, 7 (1952) pp. 117-129.
Huy et al., Brit. J. Pharmacol, 9 (1954) pp. 471-475.
Jones et al. Biochem. J., 45(1949) pp. 143-149.
Ambrosius James William
Johnson Maynard R.
Robinson Allen J.
The Dow Chemical Company
LandOfFree
Substituted phenoxyalkyl quaternary ammonium compounds as antiar does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted phenoxyalkyl quaternary ammonium compounds as antiar, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted phenoxyalkyl quaternary ammonium compounds as antiar will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1228813